S

Susmed Inc
TSE:4263

Watchlist Manager
Susmed Inc
TSE:4263
Watchlist
Price: 916 JPY 1.44% Market Closed
Market Cap: 15.5B JPY

Susmed Inc
Net Change in Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Susmed Inc
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
S
Susmed Inc
TSE:4263
Net Change in Cash
-ÂĄ448.8m
CAGR 3-Years
N/A
CAGR 5-Years
-36%
CAGR 10-Years
N/A
M3 Inc
TSE:2413
Net Change in Cash
-ÂĄ14.7B
CAGR 3-Years
N/A
CAGR 5-Years
-68%
CAGR 10-Years
N/A
EM Systems Co Ltd
TSE:4820
Net Change in Cash
ÂĄ1.2B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
S
Software Service Inc
TSE:3733
Net Change in Cash
ÂĄ2.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medley Inc
TSE:4480
Net Change in Cash
ÂĄ3.6B
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
N/A
JMDC Inc
TSE:4483
Net Change in Cash
ÂĄ8.4B
CAGR 3-Years
-31%
CAGR 5-Years
24%
CAGR 10-Years
N/A
No Stocks Found

Susmed Inc
Glance View

Market Cap
15.4B JPY
Industry
Health Care

SUSMED, Inc. engages in the development of medical equipment and software systems. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2021-12-24. The firm operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.

Intrinsic Value
637.73 JPY
Overvaluation 30%
Intrinsic Value
Price
S

See Also

What is Susmed Inc's Net Change in Cash?
Net Change in Cash
-448.8m JPY

Based on the financial report for Jun 30, 2025, Susmed Inc's Net Change in Cash amounts to -448.8m JPY.

What is Susmed Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-36%

Over the last year, the Net Change in Cash growth was -122%.

Back to Top